CRICUT INC - CLASS A (CRCT)
US22658D1000 - Common Stock
Taking everything into account, CRCT scores 6 out of 10 in our fundamental rating. CRCT was compared to 67 industry peers in the Household Durables industry. While CRCT has a great health rating, its profitability is only average at the moment. CRCT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CRCT had positive earnings in the past year.
CRCT had a positive operating cash flow in the past year.
Each year in the past 5 years CRCT has been profitable.
Of the past 5 years CRCT 4 years had a positive operating cash flow.
1.2 Ratios
CRCT has a Return On Assets of 7.14%. This is in the better half of the industry: CRCT outperforms 62.12% of its industry peers.
CRCT has a Return On Equity of 10.02%. This is comparable to the rest of the industry: CRCT outperforms 45.45% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.20%, CRCT is in the better half of the industry, outperforming 65.15% of the companies in the same industry.
CRCT had an Average Return On Invested Capital over the past 3 years of 12.70%. This is above the industry average of 10.02%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.14% | ||
| ROE | 10.02% | ||
| ROIC | 10.2% |
ROA(3y)9.17%
ROA(5y)13.29%
ROE(3y)13.3%
ROE(5y)27.96%
ROIC(3y)12.7%
ROIC(5y)24.07%
1.3 Margins
CRCT has a Profit Margin of 7.00%. This is comparable to the rest of the industry: CRCT outperforms 56.06% of its industry peers.
In the last couple of years the Profit Margin of CRCT has declined.
The Operating Margin of CRCT (10.45%) is better than 62.12% of its industry peers.
In the last couple of years the Operating Margin of CRCT has declined.
CRCT has a better Gross Margin (44.87%) than 86.36% of its industry peers.
CRCT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.45% | ||
| PM (TTM) | 7% | ||
| GM | 44.87% |
OM growth 3Y-20.65%
OM growth 5Y-2.11%
PM growth 3Y-24.24%
PM growth 5Y-13.54%
GM growth 3Y8.98%
GM growth 5Y6.53%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRCT is still creating some value.
The number of shares outstanding for CRCT has been reduced compared to 1 year ago.
Compared to 5 years ago, CRCT has less shares outstanding
CRCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
CRCT has an Altman-Z score of 5.34. This indicates that CRCT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.34, CRCT belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
CRCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 5.34 |
ROIC/WACC0.94
WACC10.89%
2.3 Liquidity
A Current Ratio of 3.16 indicates that CRCT has no problem at all paying its short term obligations.
CRCT has a better Current ratio (3.16) than 60.61% of its industry peers.
CRCT has a Quick Ratio of 1.91. This is a normal value and indicates that CRCT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.91, CRCT is in the better half of the industry, outperforming 77.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.16 | ||
| Quick Ratio | 1.91 |
3. Growth
3.1 Past
The earnings per share for CRCT have decreased strongly by -14.29% in the last year.
Measured over the past 5 years, CRCT shows a small growth in Earnings Per Share. The EPS has been growing by 2.10% on average per year.
The Revenue for CRCT has decreased by -13.68% in the past year. This is quite bad
Measured over the past years, CRCT shows a quite strong growth in Revenue. The Revenue has been growing by 17.63% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3Y-29.61%
EPS 5Y2.1%
EPS growth Q2Q0%
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y-7.25%
Revenue growth 5Y17.63%
Revenue growth Q2Q-17.65%
3.2 Future
Based on estimates for the next years, CRCT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.56% on average per year.
CRCT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.63% yearly.
EPS Next Y-3.1%
EPS Next 2Y11.26%
EPS Next 3Y11.56%
EPS Next 5YN/A
Revenue Next Year-4.16%
Revenue Next 2Y-0.07%
Revenue Next 3Y1.63%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 22.33, CRCT is valued on the expensive side.
63.64% of the companies in the same industry are cheaper than CRCT, based on the Price/Earnings ratio.
CRCT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.55, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 23.05, which indicates a rather expensive current valuation of CRCT.
CRCT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CRCT is more expensive than 63.64% of the companies in the same industry.
CRCT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.33 | ||
| Fwd PE | 23.05 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRCT indicates a somewhat cheap valuation: CRCT is cheaper than 71.21% of the companies listed in the same industry.
89.39% of the companies in the same industry are more expensive than CRCT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.39 | ||
| EV/EBITDA | 7.4 |
4.3 Compensation for Growth
The decent profitability rating of CRCT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)10.63
EPS Next 2Y11.26%
EPS Next 3Y11.56%
5. Dividend
5.1 Amount
CRCT has a Yearly Dividend Yield of 18.55%, which is a nice return.
CRCT's Dividend Yield is rather good when compared to the industry average which is at 3.45. CRCT pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, CRCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 18.55% |
5.2 History
CRCT is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
548.87% of the earnings are spent on dividend by CRCT. This is not a sustainable payout ratio.
DP548.87%
EPS Next 2Y11.26%
EPS Next 3Y11.56%
CRICUT INC - CLASS A
NASDAQ:CRCT (5/1/2024, 7:00:01 PM)
After market: 5.36 0 (0%)5.36
+0.04 (+0.75%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.16B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 18.55% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.33 | ||
| Fwd PE | 23.05 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)10.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.14% | ||
| ROE | 10.02% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 10.45% | ||
| PM (TTM) | 7% | ||
| GM | 44.87% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.16 | ||
| Quick Ratio | 1.91 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-14.29%
EPS 3Y-29.61%
EPS 5Y
EPS growth Q2Q
EPS Next Y-3.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.68%
Revenue growth 3Y-7.25%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y